Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Down -16.93% in 4 Weeks, Here's Why Masimo (MASI) Looks Ripe for a Turnaround
10:38am, Tuesday, 23'rd May 2023
The heavy selling pressure might have exhausted for Masimo (MASI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
3 Reasons to Retain Masimo (MASI) Stock in Your Portfolio
03:06pm, Wednesday, 17'th May 2023
Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.
Masimo (MASI) Q1 Earnings Surpass Estimates, Margins Down
12:12pm, Wednesday, 10'th May 2023
Masimo's (MASI) robust product shipments and continued strength in its healthcare business drive its Q1 sales.
Masimo Corporation (MASI) Q1 2023 Earnings Call Transcript
08:48pm, Tuesday, 09'th May 2023
Masimo Corporation (NASDAQ:MASI ) Q1 2023 Earnings Conference Call May 9, 2023 4:30 PM ET Company Participants Eli Kammerman - Vice President of Business Development & Investor Relations Joe Kiani - C
Masimo (MASI) Beats Q1 Earnings and Revenue Estimates
07:52pm, Tuesday, 09'th May 2023
Masimo (MASI) came out with quarterly earnings of $0.87 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $0.93 per share a year ago.
US judge declares mistrial in Apple-Masimo smartwatch trade secrets fight
07:14pm, Monday, 01'st May 2023
A U.S. judge in California on Monday declared a mistrial in Masimo Corp's potential billion-dollar smartwatch trade secret lawsuit against Apple Inc after jurors failed to reach a unanimous verdict, m
Headphone startup Nura gets acqui-hired by Denon parent, Masimo
04:55pm, Thursday, 20'th Apr 2023
Every so often, a new startup crosses your radar and reminds you how exciting hardware can be. It's a relative rarity in consumer electronics, a category dominated by corporations like Samsung, Apple
Masimo's (MASI) New FDA Approval to Improve Patient Monitoring
12:11pm, Thursday, 20'th Apr 2023
Masimo's (MASI) receipt of the FDA's clearance for the Rad-G with Temperature is expected to support clinicians in almost any care scenario.
Is Masimo (MASI) Outperforming Other Medical Stocks This Year?
11:27am, Tuesday, 18'th Apr 2023
Here is how Masimo (MASI) and Ocuphire Pharma, Inc. (OCUP) have performed compared to their sector so far this year.
Masimo (MASI) Hits 52-Week High: What's Aiding the Stock?
01:39pm, Thursday, 13'th Apr 2023
Investors are optimistic about Masimo's (MASI) slew of product launches.
Beware the Embattled CEO at Masimo
06:26pm, Wednesday, 12'th Apr 2023
Politan Capital is the activist that wants to block the potential $600 million payout to Joe Kiani.
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report?
01:48pm, Tuesday, 11'th Apr 2023
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Masimo's (MASI) New FDA Clearance to Boost Patient Monitoring
01:42pm, Tuesday, 04'th Apr 2023
Masimo's (MASI) receipt of the FDA's De Novo grant is expected to combat opioid overdoses by boosting patient monitoring.
Why Is Masimo (MASI) Up 0.2% Since Last Earnings Report?
12:56pm, Thursday, 30'th Mar 2023
Masimo (MASI) reported earnings 30 days ago. What's next for the stock?
Masimo (MASI) Unveils Freedom Smartwatch With Privacy Switch
09:59am, Wednesday, 29'th Mar 2023
Masimo's (MASI) newest wearable product seamlessly integrates continuous health tracking technology and breakthrough features.
